Submitted by Anonymous (not verified) on 17 October 2025 - 11:21
Human medicines European public assessment report (EPAR): Polivy, polatuzumab vedotin, Date of authorisation: 16/01/2020, Revision: 7, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Polivy, polatuzumab vedotin, Date of authorisation: 16/01/2020, Revision: 7, Status: Authorised